Citadel Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.4M Buy
148,669
+139,189
+1,468% +$40.1M 0.03% 1538
2025
Q4
$2.87M Sell
9,480
-40,826
-81% -$12.7M ﹤0.01% 5250
2025
Q3
$14.1M Buy
50,306
+47,688
+1,822% +$13M 0.01% 2765
2025
Q2
$632K Sell
2,618
-10,193
-80% -$2.41M ﹤0.01% 8076
2025
Q1
$3.12M Buy
12,811
+11,947
+1,383% +$3.59M ﹤0.01% 4699
2024
Q4
$284K Sell
864
-19,629
-96% -$6.66M ﹤0.01% 9764
2024
Q3
$6.86M Buy
+20,493
New +$6.51M 0.01% 3453
2024
Q2
Sell
-38,070
Closed -$11.1M 14275
2024
Q1
$13.2M Buy
38,070
+16,217
+74% +$5.33M 0.01% 2566
2023
Q4
$7.06M Buy
21,853
+16,873
+339% +$5.29M 0.01% 3313
2023
Q3
$1.79M Sell
4,980
-37,287
-88% -$14.4M ﹤0.01% 5428
2023
Q2
$16M Sell
42,267
-17,820
-30% -$7.25M 0.02% 2113
2023
Q1
$28.8M Sell
60,087
-65,877
-52% -$30.8M 0.03% 1571
2022
Q4
$53M Buy
125,964
+35,034
+39% +$14.1M 0.06% 1084
2022
Q3
$37.9M Buy
90,930
+39,151
+76% +$19.5M 0.05% 1278
2022
Q2
$25.6M Sell
51,779
-83,985
-62% -$43.7M 0.03% 1600
2022
Q1
$76.5M Buy
135,764
+127,648
+1,573% +$76.9M 0.09% 805
2021
Q4
$6.13M Sell
8,116
-536
-6% -$401K 0.01% 3935
2021
Q3
$6.45M Sell
8,652
-20,789
-71% -$15.6M 0.01% 3833
2021
Q2
$19M Buy
29,441
+25,831
+716% +$15.7M 0.02% 2153
2021
Q1
$2.06M Buy
+3,610
New +$2.14M ﹤0.01% 6306
2020
Q4
Sell
-4,748
Closed -$2.45M 10917
2020
Q3
$2.45M Sell
4,748
-15,368
-76% -$7.78M ﹤0.01% 4353
2020
Q2
$9.08M Sell
20,116
-5,202
-21% -$2.3M 0.01% 2339
2020
Q1
$8.88M Sell
25,318
-2,785
-10% -$1.02M 0.01% 1996
2019
Q4
$10.4M Sell
28,103
-94,313
-77% -$33.2M 0.01% 2155
2019
Q3
$40.7M Buy
122,416
+106,261
+658% +$34.7M 0.05% 894
2019
Q2
$5.05M Sell
16,155
-25,830
-62% -$7.73M 0.01% 3062
2019
Q1
$12.8M Buy
41,985
+21,326
+103% +$5.76M 0.02% 1769
2018
Q4
$4.8M Sell
20,659
-5,180
-20% -$1.39M 0.01% 2846
2018
Q3
$8.09M Buy
25,839
+21,541
+501% +$6.69M 0.01% 2385
2018
Q2
$1.24M Sell
4,298
-2,581
-38% -$713K ﹤0.01% 4846
2018
Q1
$1.72M Sell
6,879
-178,217
-96% -$45.4M ﹤0.01% 3966
2017
Q4
$44.2M Sell
185,096
-29,398
-14% -$7.12M 0.06% 683
2017
Q3
$47.7M Buy
214,494
+29,910
+16% +$6.73M 0.08% 573
2017
Q2
$41.8M Buy
184,584
+162,725
+744% +$35.5M 0.07% 584
2017
Q1
$4.36M Buy
21,859
+15,578
+248% +$3M 0.01% 2182
2016
Q4
$1.15M Sell
6,281
-15,450
-71% -$2.63M ﹤0.01% 3681
2016
Q3
$3.56M Buy
21,731
+1,535
+8% +$233K 0.01% 2321
2016
Q2
$2.89M Buy
20,196
+12,408
+159% +$1.77M 0.01% 2354
2016
Q1
$1.06M Sell
7,788
-1,638
-17% -$215K ﹤0.01% 3398
2015
Q4
$1.31M Buy
9,426
+7,661
+434% +$1.06M ﹤0.01% 3262
2015
Q3
$237K Sell
1,765
-11,341
-87% -$1.63M ﹤0.01% 5907
2015
Q2
$1.97M Sell
13,106
-37,879
-74% -$5.42M ﹤0.01% 3074
2015
Q1
$6.89M Sell
50,985
-33,385
-40% -$4.14M 0.01% 1720
2014
Q4
$10.2M Buy
84,370
+50,102
+146% +$5.77M 0.02% 1388
2014
Q3
$3.89M Buy
34,268
+19,004
+125% +$2.25M 0.01% 2215
2014
Q2
$1.83M Buy
15,264
+3,995
+35% +$488K ﹤0.01% 2806
2014
Q1
$1.44M Sell
11,269
-5,503
-33% -$705K ﹤0.01% 2971
2013
Q4
$2.07M Buy
16,772
+4,683
+39% +$571K ﹤0.01% 2514
2013
Q3
$1.42M Sell
12,089
-4,733
-28% -$558K ﹤0.01% 2726
2013
Q2
$1.89M Buy
+16,822
New +$1.97M ﹤0.01% 2548

Other funds holding BIO